🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective is to evaluate the cytogenetic response to Dasatinib (BMS-354...
Status
Completed
Location
Local Institution
Start Date
2007-05
Trial ID
NCT00482703
To determine if senolytic drugs reduce senescent cell burden and reduce bon...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2020-06-09
Trial ID
NCT04313634
The purpose of the study is to determine the safety and tolerability of the...
Status
Completed
Location
University Of California Medical Center
Start Date
2011-01
Trial ID
NCT01218477
Treatments Being Tested
This is a phase III study of BMS-354825 in subjects with chronic phase Phil...
Status
Completed
Location
University Of Alabama At Birmingham
Start Date
2005-07
Trial ID
NCT00123474
The purpose of this study is to determine the safety and tolerability of da...
Status
Terminated
Location
Orlando Health, Inc. M.D. Anderson Cancer Center Orlando
Start Date
2008-02
Trial ID
NCT00560352
Treatments Being Tested
This randomised clinical trial aims to study osteoporosis as a disease of a...
Status
Active Not Recruiting
Location
Odense University Hospital
Start Date
2023-09-06
Trial ID
NCT06018467
Treatments Being Tested
The purpose of this study is to find the recommended doses of dasatinib and...
Status
Completed
Location
University of Chicago
Start Date
2007-07
Trial ID
NCT00439270
The purpose of this study is to determine the recommended dose for the comb...
Status
Withdrawn
Location
Local Institution
Start Date
2009-05
Trial ID
NCT00872976
The primary objective of this study is to determine the maximum tolerated d...
Status
Completed
Location
Local Institution
Start Date
2007-01
Trial ID
NCT00339144
This study proposes to evaluate the number of chronic, Grade 1 or 2, non-he...
Status
Completed
Location
Pacific Cancer Medical Center
Start Date
2012-12
Trial ID
NCT01660906
Treatments Being Tested